This link will take you to the TrialReach website, the content for which Janssen R&D, LLC is not responsible and to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit.

Back Continue
This site is intended for U.S. residents only.
Spartan Study - Prostate Cancer Clinical Research

Researching an Oral Investigational Medication for Slowing Prostate Cancer Progression in Men with Non-Metastatic Disease and Rising PSA Levels

The SPARTAN study is evaluating an oral investigational medication to determine if it can slow prostate cancer from spreading beyond the prostate to other parts of the body. If you have prostate cancer that has not spread beyond the prostate (non-metastatic) and you have rising prostate-specific antigen (PSA) levels despite treatment, you may be eligible to participate.